HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
Open Access
- 6 July 2018
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 6 (3), 1-10
- https://doi.org/10.14218/jcth.2018.00016
Abstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is a complex clinical entity that has an estimated worldwide prevalence of 1–15%. Most clinical studies have shown that progression of disease is faster in HBV-HCV coinfected patients compared to those with monoinfection. Hepatocellular carcinoma development appears to have higher rate in coinfections. Viral replication in coinfected cells is characterized by a dominance of HCV over HBV replication. There are no established guidelines for treatment of HBV-HCV coinfection. Studies on interferon-based therapies and direct-acting antivirals have shown varying levels of efficacy. Clinical reports have indicated that treatment of HCV without suppression of HBV increases the risk for HBV reactivation. In this review, we appraise studies on both direct-acting antivirals and interferon-based therapies to evaluate the efficacy and rates of reactivation with each regimen. Screening for and prevention of coinfection are important to prevent serious HBV reactivations.Keywords
This publication has 74 references indexed in Scilit:
- Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular CarcinomaPLOS ONE, 2013
- Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of LiverAdvances in Virology, 2013
- Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort studyBMC Cancer, 2012
- Comparable Ten-Year Outcome in Hemodialysis Patients with Hepatitis C Virus and Hepatitis B Virus Coinfection and Single Hepatitis B Virus InfectionBlood Purification, 2011
- Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in HarmonyCurrent Hepatitis Reports, 2010
- Analysis of the efficacy of treatment with peginterferon α‐2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virusLiver International, 2009
- NS5A protein of HCV enhances HBV replication and resistance to interferon responseBiochemical and Biophysical Research Communications, 2007
- Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Can Coinfect the Same Hepatocyte in the Liver of Patients with Chronic HCV and Occult HBV InfectionJournal of Virology, 2005
- Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infectionJournal of Hepatology, 2004